What's next for immunotherapy in locally advanced NSCLC?
Publication
, Journal Article
Ready, NE
Published in: Clin Adv Hematol Oncol
May 2021
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
May 2021
Volume
19
Issue
5
Start / End Page
302 / 304
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Carcinoma, Non-Small-Cell Lung
Citation
APA
Chicago
ICMJE
MLA
NLM
Ready, N. E. (2021). What's next for immunotherapy in locally advanced NSCLC? Clin Adv Hematol Oncol, 19(5), 302–304.
Ready, Neal Edward. “What's next for immunotherapy in locally advanced NSCLC?” Clin Adv Hematol Oncol 19, no. 5 (May 2021): 302–4.
Ready NE. What's next for immunotherapy in locally advanced NSCLC? Clin Adv Hematol Oncol. 2021 May;19(5):302–4.
Ready, Neal Edward. “What's next for immunotherapy in locally advanced NSCLC?” Clin Adv Hematol Oncol, vol. 19, no. 5, May 2021, pp. 302–04.
Ready NE. What's next for immunotherapy in locally advanced NSCLC? Clin Adv Hematol Oncol. 2021 May;19(5):302–304.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
May 2021
Volume
19
Issue
5
Start / End Page
302 / 304
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Immunologic Factors
- Humans
- Carcinoma, Non-Small-Cell Lung